
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Palmitoylethanolamide
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II
Recipient : University of California, Irvine
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation
Details : Palmitoylethanolamide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Tibial Fractures.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 08, 2022
Lead Product(s) : Palmitoylethanolamide
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Recipient : University of California, Irvine
Deal Size : Inapplicable
Deal Type : Inapplicable
